Figure S6 from Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

<p>Figure S6. Flowcytometric analysis for ROS detection following 48 h vehicle treated (cont), 0.1 μM of azacitidine treated (A 0.1), 1.0 μM of azacitidine treated (A 1.0), 0.1 μM of venetoclax treated (V 0.1), 0.5 μM of venetoclax treated (V 0.5), 0.1 μM of azacitidine and 0.1 μM of venetoclax (A 0.1+V 0.1), 1.0 μM of azacitidine and 0.1 μM of venetoclax (A 1.0 + V 0.1), 0.1 μM of azacitidine and 0.5 μM of venetoclax (A 0.1 + V 0.5) and 1.0 μM of azacitidine and 0.5 μM of venetoclax (A 1.0 + V 0.5).</p>